210 related articles for article (PubMed ID: 35697996)
1. The Benefit of Bariatric Surgery on Histological Features of Metabolic Associated Fatty Liver Disease Assessed Through Noninvasive Methods.
Meneses D; Olveira A; Corripio R; Méndez MD; Romero M; Calvo-Viñuelas I; González-Pérez-de-Villar N; de-Cos-Blanco AI
Obes Surg; 2022 Aug; 32(8):2682-2695. PubMed ID: 35697996
[TBL] [Abstract][Full Text] [Related]
2. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
[TBL] [Abstract][Full Text] [Related]
3. Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis.
Taitano AA; Markow M; Finan JE; Wheeler DE; Gonzalvo JP; Murr MM
J Gastrointest Surg; 2015 Mar; 19(3):429-36; discussion 436-7. PubMed ID: 25537957
[TBL] [Abstract][Full Text] [Related]
4. Bariatric Surgery in Nonalcoholic Fatty Liver Disease (NAFLD): Impact Assessment Using Paired Liver Biopsy and Fibroscan.
Agarwal L; Aggarwal S; Shalimar ; Yadav R; Dattagupta S; Garg H; Agarwal S
Obes Surg; 2021 Feb; 31(2):617-626. PubMed ID: 33052552
[TBL] [Abstract][Full Text] [Related]
5. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: "NASHOST" prospective observational trial.
Praveen Raj P; Gomes RM; Kumar S; Senthilnathan P; Karthikeyan P; Shankar A; Palanivelu C
Surg Obes Relat Dis; 2015; 11(6):1315-22. PubMed ID: 26003897
[TBL] [Abstract][Full Text] [Related]
6. Application of Scores Assessing Histological Activity and Estimated Long-Term Risk Analysis of Hepatic Decompensation of Non-Alcoholic Fatty Liver Disease in Individuals Undergoing Bariatric Surgery.
Hatto M; Ivano VK; Gestic MA; Utrini MP; Chaim FDM; Callejas-Neto F; Chaim EA; Cazzo E
Obes Surg; 2023 May; 33(5):1580-1586. PubMed ID: 37004688
[TBL] [Abstract][Full Text] [Related]
7. Evolution of Non-alcoholic Fatty Liver Disease (NAFLD) Biomarkers in Response to Weight Loss 1 Year After Bariatric Surgery-a Post Hoc Analysis of the FibroTest Prospective Study.
Codjia T; Rebibo L; François A; Lagnel C; Huet E; Bekri S; Pattou F; Régimbeau JM; Schwarz L
Obes Surg; 2021 Aug; 31(8):3548-3556. PubMed ID: 33844174
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of Hepamet Fibrosis Scoring System-A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis.
Ampuero J; Pais R; Aller R; Gallego-Durán R; Crespo J; García-Monzón C; Boursier J; Vilar E; Petta S; Zheng MH; Escudero D; Calleja JL; Aspichueta P; Diago M; Rosales JM; Caballería J; Gómez-Camarero J; Lo Iacono O; Benlloch S; Albillos A; Turnes J; Banales JM; Ratziu V; Romero-Gómez M;
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):216-225.e5. PubMed ID: 31195161
[TBL] [Abstract][Full Text] [Related]
9. Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis.
Lassailly G; Caiazzo R; Ntandja-Wandji LC; Gnemmi V; Baud G; Verkindt H; Ningarhari M; Louvet A; Leteurtre E; Raverdy V; Dharancy S; Pattou F; Mathurin P
Gastroenterology; 2020 Oct; 159(4):1290-1301.e5. PubMed ID: 32553765
[TBL] [Abstract][Full Text] [Related]
10. Significant fibrosis assessed by liver biopsy among Chinese bariatric surgery patients: A prospective cross-sectional study.
Huang Y; Dong S; Wang C; Dong Z; Chen W
Front Endocrinol (Lausanne); 2023; 14():1090598. PubMed ID: 36793287
[TBL] [Abstract][Full Text] [Related]
11. Fibrogenesis Marker PRO-C3 Is Higher in Advanced Liver Fibrosis and Improves in Patients Undergoing Bariatric Surgery.
Bel Lassen P; Nori N; Bedossa P; Genser L; Aron-Wisnewsky J; Poitou C; Surabattula R; Juul Nielsen M; Asser Karsdal M; Julie Leeming D; Schuppan D; Clément K
J Clin Endocrinol Metab; 2022 Mar; 107(4):e1356-e1366. PubMed ID: 34905051
[TBL] [Abstract][Full Text] [Related]
12. Performance of Noninvasive Liver Fibrosis Scores in the Morbid Obese Patient, Same Scores but Different Thresholds.
Meneses D; Olveira A; Corripio R; Del Carmen Méndez M; Romero M; Calvo-Viñuelas I; Herranz L; Vicent D; de-Cos-Blanco AI
Obes Surg; 2020 Jul; 30(7):2538-2546. PubMed ID: 32157523
[TBL] [Abstract][Full Text] [Related]
13. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
Lassailly G; Caiazzo R; Buob D; Pigeyre M; Verkindt H; Labreuche J; Raverdy V; Leteurtre E; Dharancy S; Louvet A; Romon M; Duhamel A; Pattou F; Mathurin P
Gastroenterology; 2015 Aug; 149(2):379-88; quiz e15-6. PubMed ID: 25917783
[TBL] [Abstract][Full Text] [Related]
14. Remission of nonalcoholic steatohepatitis after bariatric surgery: a single referral center cohort study.
Drai C; Chierici A; Pavone G; Benamran D; Alromayan M; Alamri A; Anty R; Liddo G; Iannelli A
Surg Obes Relat Dis; 2024 May; 20(5):482-489. PubMed ID: 38195314
[TBL] [Abstract][Full Text] [Related]
15. Weight Loss After Bariatric Surgery Predicts an Improvement in the Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score.
Yeo SC; Ong WM; Cheng KSA; Tan CH
Obes Surg; 2019 Apr; 29(4):1295-1300. PubMed ID: 30635812
[TBL] [Abstract][Full Text] [Related]
16. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years.
Furuya CK; de Oliveira CP; de Mello ES; Faintuch J; Raskovski A; Matsuda M; Vezozzo DC; Halpern A; Garrido AB; Alves VA; Carrilho FJ
J Gastroenterol Hepatol; 2007 Apr; 22(4):510-4. PubMed ID: 17376042
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive fibrosis tools in NAFLD: validation of APRI, BARD, FIB-4, NAFLD fibrosis score, and Hepamet fibrosis score in a Portuguese population.
Rigor J; Diegues A; Presa J; Barata P; Martins-Mendes D
Postgrad Med; 2022 May; 134(4):435-440. PubMed ID: 35332833
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive assessment of hepatic steatosis and fibrosis in patients with severe obesity.
Coccia F; Testa M; Guarisco G; Bonci E; Di Cristofano C; Silecchia G; Leonetti F; Gastaldelli A; Capoccia D
Endocrine; 2020 Mar; 67(3):569-578. PubMed ID: 31858390
[TBL] [Abstract][Full Text] [Related]
19. Bariatric Surgery Improves Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis.
Zhou H; Luo P; Li P; Wang G; Yi X; Fu Z; Sun X; Cui B; Zhu L; Zhu S
Obes Surg; 2022 Jun; 32(6):1872-1883. PubMed ID: 35386040
[TBL] [Abstract][Full Text] [Related]
20. Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity.
Li YJ; Baumert BO; Stratakis N; Goodrich JA; Wu HT; He JX; Zhao YQ; Aung MT; Wang HX; Eckel SP; Walker DI; Valvi D; La Merrill MA; Ryder JR; Inge TH; Jenkins T; Sisley S; Kohli R; Xanthakos SA; Baccarelli AA; McConnell R; Conti DV; Chatzi L
World J Gastroenterol; 2024 Jan; 30(4):332-345. PubMed ID: 38313232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
